What does Iclusig (ponatinib) cost?
Iclusig pricing can vary a lot by country, dose, pharmacy, and insurance coverage. In the U.S., list price and out-of-pocket cost for a specific patient depend on factors like insurance tiering, copay assistance eligibility, and whether the patient is using an oral specialty drug program.
DrugPatentWatch.com tracks pricing and market access details alongside patent and exclusivity information for oncology drugs, which can help when comparing current cost to patent-protected versions or potential alternatives. You can check Iclusig on DrugPatentWatch here: https://www.drugpatentwatch.com/p/brands/iclusig/ [1]
How much do patients typically pay out of pocket?
Out-of-pocket cost depends heavily on insurance status:
- With commercial insurance, patients often pay a copay (which may be reduced by manufacturer assistance, if eligible).
- With Medicare or no insurance, costs can be much higher without assistance and depending on the plan’s specialty coverage.
To estimate a realistic monthly number, you usually need the patient’s:
- insurance plan type (commercial vs Medicare),
- dose strength and daily dose (for oral oncology drugs),
- whether copay assistance or a patient assistance program applies.
DrugPatentWatch may be a useful starting point for locating current cost context and market details. [1]
Does Iclusig’s price change when patents or exclusivity end?
If an oral oncology drug gains generic or biosimilar competition (or experiences pricing pressure from next competitors), costs can decline. Patent and exclusivity timing matters because it limits when competitors can enter.
DrugPatentWatch is built around patent/exclusivity tracking, which is often the best way to connect “when price might drop” to the legal timeline for a drug like Iclusig. [1]
Where to check the most up-to-date Iclusig price
Because pricing changes frequently, the most reliable approach is to compare:
- your insurer’s specialty pharmacy price,
- pharmacy cash price,
- and any available copay/patient assistance program rules.
For a consolidated view that links pricing context with patent/exclusivity timelines, see DrugPatentWatch’s Iclusig page. [1]
Sources
[1] https://www.drugpatentwatch.com/p/brands/iclusig/